Skip to content

Bridging the Gap to Adult Diabetes Care

Bridging the Gap to Optimize Care and Outcomes for Youth With Diabetes Between Pediatric and Adult Diabetes Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03781973
Enrollment
484
Registered
2018-12-20
Start date
2019-06-01
Completion date
2022-12-31
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1diabetes

Keywords

Transition to adult care, Glycemic control

Brief summary

Adolescents with type 1 diabetes face particular challenges related to having a chronic illness that requires daily intensive self-management and medical follow-up during a period when their social, developmental, educational, and family situations are in flux. When transitioning from pediatric to adult care, over a third of youth have a care gap of \>6 months. During this vulnerable period youth are at risk for acute life-threatening complications such as diabetic ketoacidosis, and for poor glycemic control, which confers an increased risk of chronic diabetes complications. Gaps in care may be a result of deficiencies in transition processes causing some young people to be poorly prepared for adult care and dissatisfied with the transition process. Ineffective transition can lead to decreased frequency of diabetes visits and an increased risk of adverse events in young adulthood. Further, risk factors such as psychiatric comorbidity and behavioural problems in adolescents with type 1 diabetes are associated with poor outcomes in early adulthood. Quality improvement initiatives can be designed to optimize care processes such as referral systems to adult diabetes providers. Our overall objective is to optimize care and outcomes for youth with diabetes as they transition to adult care. Specific Aim 1: To improve glycemic control in youth around the time of transition from pediatric to adult diabetes care Specific Aim 2: To evaluate the fidelity and quality of a quality improvement intervention designed to improve transition care processes and to identify contextual factors associated with variation in outcomes.

Interventions

BEHAVIORALData platform +Quality Performance feedback reports

Teams from each of the participating sites will attend the webinars. Each site will share an example of a QI initiative that they are executing and describe the success and challenges.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

An intervention with integrated components

Eligibility

Sex/Gender
ALL
Age
16 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* All youth with a clinical diagnosis of type 1 diabetes followed at participating centres at the time of their final pediatric clinic visit between Jan 1, 2018 and Dec 31, 2020. * Participants will be transitioning to Adult Care (ages \ 16-19 yrs). * Capacity to read and understand English (we estimate that \>95% of participants will fulfill this requirement). * Capacity to consent for themselves.

Exclusion criteria

* Individuals with non-type 1 diabetes. * Individuals with type 1 diabetes who move out of Ontario within 12 months after their final pediatric visit. * Individuals with type 1 diabetes who do not have the capacity to consent for themselves.

Design outcomes

Primary

MeasureTime frameDescription
HbA1cHbA1c value up to 12 months after the final pediatric visit.Hemoglobin A1c

Secondary

MeasureTime frameDescription
Number of Diabetes-related admissions, ED visits, deathnumber of occurrences up to12 months after the final pediatric visit.The occurrence of at least one diabetes-related admissions or emergency department visit or death
Time from the final pediatric visit to the first adult diabetes visitTime in months up to 12 months after the final pediatric visitidentified using physician service claims and defined as the first diabetes office visit by an adult endocrinologist, internist, or family physician

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026